The UK diagnostic imaging and pathology market was valued at a combined total of £6.2bn in 2018, but the vast majority remained delivered in-house by the NHS despite ongoing capacity constraints, according to the latest research from LaingBuisson. Initial findings from LaingBuisson’s forthcoming UK Diagnostics Report, due for publication next month, indicate that just under…